Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Journal of Pharmaceutical and Medicinal Chemistry

Volume  5, Issue 1, January-June 2019, Pages 27-39
 

Original Article

Evolution in Medicinal Chemistry of Prazolopyrimidine Derivatives as Anticancer Agents

Azhar Iqbal1, Asif Husain2, Mohammad Rashid3, Mohammad Taha Kazmi4, Aftab Ahmad5, Khursheed A. Ansari6

1,3,4Research Scholar 2Professor, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India, 5Associate Professor, Health Information Technology Department, Jeddah Community College, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia. 6Associate Professor, Department of Tashreehul Badan, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi 110062, India.

Choose an option to locate / access this Article:
60 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/jpmc.2395.6615.5119.4

Abstract

Pyrazolopyrimidines are the fused heterocyclic ring systems which structurally resemble with purines, and exhibit important biological actions. Pyrazolopyrimidines derivatives have great importance in the field of chemical synthesis, agriculture and pharmaceutical industries due to their wide range of applications. Over the past few decades, researchers have focused their research on the synthesis of novel pyrazolopyrimidine derivatives. The pyrazolopyrimidines heterocyclic ring is an integral part of various synthetic compounds with wide range of therapeutic and pharmacological potentials like anti-inflammatory, antibacterial, anticancer, antifungal, antiviral, anticonvulsant, anti-tubercular, etc Many marketed drugs are pyrazolopyrimidine derivatives like antiviral drugs which include acyclovir, ganciclovir, didanosine, abacavir and adefovir. Due to the wide scope of pharmacological potentials of pyrazolopyrimidine derivatives, research community has shown great interest to discover new pyrazolopyrimidines having potent bioactivities with no or lesser side effects. This review summarizes the recent developments on the synthetic approaches, mechanism of action and anticancer activity of pyrazolopyrimidines.

Keywords: Pyrazolopyrimidines, Anticancer


Corresponding Author : Asif Husain